Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case reportLearning points

Febrile neutropenia in a patient with non-small-cell lung cancer treated with atezolizumab: A case reportLearning points

Hematological immune-related adverse events (hem-irAEs) related to immunotherapy have not been extensively characterized, and there is no report of neutropenia caused by atezolizumab administration. Herein, we report a case of febrile neutropenia caused by a hem-irAEs due to atezolizumab, which was...

Full description

Bibliographic Details
Main Authors: Kyosuke Seguchi, Kei Nakashima, Toshiki Terao, Gaku Takeshita, Tatsuya Nagai, Yu Tanaka
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Non-small-cell lung cancer
Hematologic immune-related adverse event
Atezolizumab
Neutropenia
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007121001015

Similar Items

Similar Items